Letno srečanje ASCO

Povzetek

Ključne besede

Podatki

Jezik:	Slovenski jezik
Leto izida:	2015
Tipologija:	1.04 - Strokovni članek
Organizacija:	OI - Onkološki inštitut Ljubljana
UDK:	616-006
COBISS:	2139771
ISSN:	1408-1741
Matična publikacija:	Onkologija
Št. ogledov:	2865
Št. prenosov:	624
Ocena:	0 (0 glasov)
Metapodatki:

Ostali podatki

Sekundarni jezik:	Angleški jezik
Sekundarni naslov:	ASCO Annual Meeting
Sekundarni povzetek:	In the end of May this year, Chicago hosted the traditional annual meeting of oncologists from around the world, which was organised by the American Society of Clinical Oncology (ASCO). Once again, the meeting was attended by more than 30,000 oncologists and other scientists from all over the world. The main topic of this year’s ASCO meeting was definitely cancer immunotherapy. For many years, we have hoped to be able to destroy or at least control cancer cells by stimulating the organism’s own defence. There have been some ups but mostly many downs of immunotherapy. Interferons, interleukins and vaccines have shown a very small level of efficacy, and, even so, only in some types of cancer, alongside a disproportionally high toxicity. A breakthrough was achieved a few years ago, when new immuno-medicines, inhibitors of control switches in T lymphocytes (so-called checkpoint inhibitors), were introduced into clinical trials. In many types of cancer, these medicines led to remissions, which were, most importantly, long-term in patients with remission.
URN:	URN:NBN:SI
Strani:	str. 30-32
Letnik:	ǂLetn. ǂ19
Zvezek:	ǂšt. ǂ1
Čas izdaje:	jun. 2015
ID:	10917363